Cargando…
Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging
AIMS: Diabetic retinopathy (DR) is the most common cause of vision loss in the working age. This research aimed to develop an artificial intelligence (AI) machine learning model which can predict the development of referable DR from fundus imagery of otherwise healthy eyes. METHODS: Our researchers...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809299/ http://dx.doi.org/10.1136/bmjophth-2022-001140 |
_version_ | 1784863091181223936 |
---|---|
author | Rom, Yovel Aviv, Rachelle Ianchulev, Tsontcho Dvey-Aharon, Zack |
author_facet | Rom, Yovel Aviv, Rachelle Ianchulev, Tsontcho Dvey-Aharon, Zack |
author_sort | Rom, Yovel |
collection | PubMed |
description | AIMS: Diabetic retinopathy (DR) is the most common cause of vision loss in the working age. This research aimed to develop an artificial intelligence (AI) machine learning model which can predict the development of referable DR from fundus imagery of otherwise healthy eyes. METHODS: Our researchers trained a machine learning algorithm on the EyePACS data set, consisting of 156 363 fundus images. Referrable DR was defined as any level above mild on the International Clinical Diabetic Retinopathy scale. RESULTS: The algorithm achieved 0.81 area under receiver operating curve (AUC) when averaging scores from multiple images on the task of predicting development of referrable DR, and 0.76 AUC when using a single image. CONCLUSION: Our results suggest that risk of DR may be predicted from fundus photography alone. Prediction of personalised risk of DR may become key in treatment and contribute to patient compliance across the board, particularly when supported by further prospective research. |
format | Online Article Text |
id | pubmed-9809299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-98092992023-01-04 Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging Rom, Yovel Aviv, Rachelle Ianchulev, Tsontcho Dvey-Aharon, Zack BMJ Open Ophthalmol Retina AIMS: Diabetic retinopathy (DR) is the most common cause of vision loss in the working age. This research aimed to develop an artificial intelligence (AI) machine learning model which can predict the development of referable DR from fundus imagery of otherwise healthy eyes. METHODS: Our researchers trained a machine learning algorithm on the EyePACS data set, consisting of 156 363 fundus images. Referrable DR was defined as any level above mild on the International Clinical Diabetic Retinopathy scale. RESULTS: The algorithm achieved 0.81 area under receiver operating curve (AUC) when averaging scores from multiple images on the task of predicting development of referrable DR, and 0.76 AUC when using a single image. CONCLUSION: Our results suggest that risk of DR may be predicted from fundus photography alone. Prediction of personalised risk of DR may become key in treatment and contribute to patient compliance across the board, particularly when supported by further prospective research. BMJ Publishing Group 2022-12-29 /pmc/articles/PMC9809299/ http://dx.doi.org/10.1136/bmjophth-2022-001140 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Retina Rom, Yovel Aviv, Rachelle Ianchulev, Tsontcho Dvey-Aharon, Zack Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title | Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title_full | Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title_fullStr | Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title_full_unstemmed | Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title_short | Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
title_sort | predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging |
topic | Retina |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809299/ http://dx.doi.org/10.1136/bmjophth-2022-001140 |
work_keys_str_mv | AT romyovel predictingthefuturedevelopmentofdiabeticretinopathyusingadeeplearningalgorithmfortheanalysisofnoninvasiveretinalimaging AT avivrachelle predictingthefuturedevelopmentofdiabeticretinopathyusingadeeplearningalgorithmfortheanalysisofnoninvasiveretinalimaging AT ianchulevtsontcho predictingthefuturedevelopmentofdiabeticretinopathyusingadeeplearningalgorithmfortheanalysisofnoninvasiveretinalimaging AT dveyaharonzack predictingthefuturedevelopmentofdiabeticretinopathyusingadeeplearningalgorithmfortheanalysisofnoninvasiveretinalimaging |